Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy

Abstract Neurodegenerative diseases are characterized by the accumulation of specific phosphorylated protein aggregates in the brain, such as hyperphosphorylated tau (hp-tau) in tauopathies and phosphorylated α-synuclein (p-αSyn) in α-synucleinopathies. The simultaneous accumulation of different pro...

Full description

Bibliographic Details
Main Authors: Yuta Takaichi, James K. Chambers, Hiroyuki Inoue, Yasuhisa Ano, Akihiko Takashima, Hiroyuki Nakayama, Kazuyuki Uchida
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Acta Neuropathologica Communications
Subjects:
Tau
Online Access:http://link.springer.com/article/10.1186/s40478-020-00969-8
id doaj-c8b159b325814c69a422f1aa5c3eb3d5
record_format Article
spelling doaj-c8b159b325814c69a422f1aa5c3eb3d52020-11-25T03:59:22ZengBMCActa Neuropathologica Communications2051-59602020-06-018111410.1186/s40478-020-00969-8Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathyYuta Takaichi0James K. Chambers1Hiroyuki Inoue2Yasuhisa Ano3Akihiko Takashima4Hiroyuki Nakayama5Kazuyuki Uchida6Laboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of TokyoLaboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of TokyoLaboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of TokyoResearch Laboratories for Health Science & Food Technologies and the Central Laboratories for Key Technologies, Kirin Company Ltd.Department of Life Science, Faculty of Science, Gakushuin UniversityLaboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of TokyoLaboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of TokyoAbstract Neurodegenerative diseases are characterized by the accumulation of specific phosphorylated protein aggregates in the brain, such as hyperphosphorylated tau (hp-tau) in tauopathies and phosphorylated α-synuclein (p-αSyn) in α-synucleinopathies. The simultaneous accumulation of different proteins is a common event in many neurodegenerative diseases. We herein describe the detection of the phosphorylation and dimerization of αSyn and activation of GSK-3β, a major kinase known to phosphorylate tau and αSyn, in the brains of rTg4510 mice that overexpress human P301L mutant tau. Immunohistochemistry showed p-αSyn aggregates in rTg4510 mice, which were suppressed by doxycycline-mediated decreases in mutant tau expression levels. A semi-quantitative analysis revealed a regional correlation between hp-tau and p-αSyn accumulation in rTg4510 mice. Furthermore, proteinase K-resistant αSyn aggregates were found in the region with excessive hp-tau accumulation in rTg4510 mice, and these aggregates were morphologically different from proteinase K-susceptible p-αSyn aggregates. Western blotting revealed decreases in p-αSyn monomers in TBS- and sarkosyl-soluble fractions and increases in ubiquitinated p-αSyn dimers in sarkosyl-soluble and insoluble fractions in rTg4510 mice. Furthermore, an activated form of GSK-3β was immunohistochemically detected within cells containing both hp-tau and p-αSyn aggregates. A semi-quantitative analysis revealed that increased GSK-3β activity strongly correlated with hp-tau and p-αSyn accumulation in rTg4510 mice. Collectively, the present results suggest that the overexpression of human P301L mutant tau promoted the phosphorylation and dimerization of endogenous αSyn by activating GSK-3β in rTg4510 mice. This synergic effect between tau, αSyn, and GSK-3β may be involved in the pathophysiology of several neurodegenerative diseases that show the accumulation of both tau and αSyn.http://link.springer.com/article/10.1186/s40478-020-00969-8α-SynucleinTauPhosphorylationOligomerizationGSK-3βrTg4510
collection DOAJ
language English
format Article
sources DOAJ
author Yuta Takaichi
James K. Chambers
Hiroyuki Inoue
Yasuhisa Ano
Akihiko Takashima
Hiroyuki Nakayama
Kazuyuki Uchida
spellingShingle Yuta Takaichi
James K. Chambers
Hiroyuki Inoue
Yasuhisa Ano
Akihiko Takashima
Hiroyuki Nakayama
Kazuyuki Uchida
Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy
Acta Neuropathologica Communications
α-Synuclein
Tau
Phosphorylation
Oligomerization
GSK-3β
rTg4510
author_facet Yuta Takaichi
James K. Chambers
Hiroyuki Inoue
Yasuhisa Ano
Akihiko Takashima
Hiroyuki Nakayama
Kazuyuki Uchida
author_sort Yuta Takaichi
title Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy
title_short Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy
title_full Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy
title_fullStr Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy
title_full_unstemmed Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy
title_sort phosphorylation and oligomerization of α-synuclein associated with gsk-3β activation in the rtg4510 mouse model of tauopathy
publisher BMC
series Acta Neuropathologica Communications
issn 2051-5960
publishDate 2020-06-01
description Abstract Neurodegenerative diseases are characterized by the accumulation of specific phosphorylated protein aggregates in the brain, such as hyperphosphorylated tau (hp-tau) in tauopathies and phosphorylated α-synuclein (p-αSyn) in α-synucleinopathies. The simultaneous accumulation of different proteins is a common event in many neurodegenerative diseases. We herein describe the detection of the phosphorylation and dimerization of αSyn and activation of GSK-3β, a major kinase known to phosphorylate tau and αSyn, in the brains of rTg4510 mice that overexpress human P301L mutant tau. Immunohistochemistry showed p-αSyn aggregates in rTg4510 mice, which were suppressed by doxycycline-mediated decreases in mutant tau expression levels. A semi-quantitative analysis revealed a regional correlation between hp-tau and p-αSyn accumulation in rTg4510 mice. Furthermore, proteinase K-resistant αSyn aggregates were found in the region with excessive hp-tau accumulation in rTg4510 mice, and these aggregates were morphologically different from proteinase K-susceptible p-αSyn aggregates. Western blotting revealed decreases in p-αSyn monomers in TBS- and sarkosyl-soluble fractions and increases in ubiquitinated p-αSyn dimers in sarkosyl-soluble and insoluble fractions in rTg4510 mice. Furthermore, an activated form of GSK-3β was immunohistochemically detected within cells containing both hp-tau and p-αSyn aggregates. A semi-quantitative analysis revealed that increased GSK-3β activity strongly correlated with hp-tau and p-αSyn accumulation in rTg4510 mice. Collectively, the present results suggest that the overexpression of human P301L mutant tau promoted the phosphorylation and dimerization of endogenous αSyn by activating GSK-3β in rTg4510 mice. This synergic effect between tau, αSyn, and GSK-3β may be involved in the pathophysiology of several neurodegenerative diseases that show the accumulation of both tau and αSyn.
topic α-Synuclein
Tau
Phosphorylation
Oligomerization
GSK-3β
rTg4510
url http://link.springer.com/article/10.1186/s40478-020-00969-8
work_keys_str_mv AT yutatakaichi phosphorylationandoligomerizationofasynucleinassociatedwithgsk3bactivationinthertg4510mousemodeloftauopathy
AT jameskchambers phosphorylationandoligomerizationofasynucleinassociatedwithgsk3bactivationinthertg4510mousemodeloftauopathy
AT hiroyukiinoue phosphorylationandoligomerizationofasynucleinassociatedwithgsk3bactivationinthertg4510mousemodeloftauopathy
AT yasuhisaano phosphorylationandoligomerizationofasynucleinassociatedwithgsk3bactivationinthertg4510mousemodeloftauopathy
AT akihikotakashima phosphorylationandoligomerizationofasynucleinassociatedwithgsk3bactivationinthertg4510mousemodeloftauopathy
AT hiroyukinakayama phosphorylationandoligomerizationofasynucleinassociatedwithgsk3bactivationinthertg4510mousemodeloftauopathy
AT kazuyukiuchida phosphorylationandoligomerizationofasynucleinassociatedwithgsk3bactivationinthertg4510mousemodeloftauopathy
_version_ 1724454434505752576